We assessed CD73 expression across these subsets and found that it was significantly higher on TN cells compared to TCM, TEM, and TEMRA cells, indicating that CD73 is downregulated in CD8+ cells following antigenic stimulation, a pattern observed in both DLBCL patients and healthy individuals (Figures 2A,B). The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.